← All organizations

Tetra Discovery Partners

For profitWebsite ↗

Also known as: Tetra Discovery Partners

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 30, 2022

Acquired by Shionogi on May 26, 2020

Timeline

2010s

Jun 1, 2010
Tetra Discovery Partners— Founded

2020s

May 26, 2020
Shionogi— Acquired By

Drugs by trial phase (3 distinct, 9 trials)

Phase 3 (1 own, 0 via acquisition)

bpn14770

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

NCT05367960Lead sponsorPhase 3Sep 30, 2022
NCT05358886Lead sponsorPhase 3Jun 30, 2022
NCT05163808Lead sponsorPhase 2/Phase 3Dec 15, 2021
NCT04044781Lead sponsorPhase 1Oct 31, 2019
NCT03817684Lead sponsorPhase 2Apr 30, 2019
NCT03817684Study directorPhase 2Apr 30, 2019
NCT03569631Lead sponsorPhase 2Jun 25, 2018
NCT03030105Lead sponsorPhase 1Jan 1, 2017
NCT02840279Study chairPhase 1Jun 1, 2016
NCT02840279Lead sponsorPhase 1Jun 1, 2016
NCT02648672Lead sponsorPhase 1Dec 1, 2015
NCT02648672Study chairPhase 1Dec 1, 2015

Details

Founded: Grand Rapids, MI, US Jun 1, 2010
Last known activity: Sep 30, 2022